サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1571427

バルーン弁形成術装置の市場規模、シェア、動向分析レポート：用途別、最終用途別、地域別、セグメント別予測、2024年～2030年

Balloon Valvuloplasty Devices Market Size, Share & Trends Analysis Report By Application (Aortic Valve Stenosis, Pulmonary Valve Stenosis), By End-use (Hospitals, Ambulatory Surgical Centers), By Region, And Segment Forecasts, 2024 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 100 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.74円
バルーン弁形成術装置の市場規模、シェア、動向分析レポート：用途別、最終用途別、地域別、セグメント別予測、2024年～2030年
出版日: 2024年09月02日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

バルーン弁形成術装置市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、バルーン弁形成術装置の世界市場規模は2024年から2030年にかけて4.1%のCAGRを記録し、2030年までに30億2,000万米ドルに達する見込みです。

心臓弁膜症を含む心血管疾患の有病率の増加、新製品の発売、規制当局の承認、高度なヘルスケアインフラが、北米におけるバルーン弁形成術装置の需要を牽引しています。リウマチ性心疾患（RHD）は、リウマチ熱による心臓弁の損傷から生じる重篤な心血管疾患です。

米国心臓協会が2024年4月に発表した報告書によると、心臓弁膜症（VHD）は米国で最も蔓延している健康状態の一つであり、成人人口の約2.5％が罹患しています。大動脈弁疾患と僧帽弁疾患はVHDの中で最も多く診断されるタイプであり、バルーン弁形成術のような効果的な治療オプションが、この増大する健康上の懸念に対処するために不可欠であることがさらに強調されています。

認知度の向上とスクリーニング・プログラムが市場の成長を後押ししています。例えば、2024年9月、世界・ハート・ハブは、2040年までに2倍、2060年までに3倍になると予想される心臓弁膜症の有病率の上昇を強調するキャンペーンを開始しました。こうした取り組みは、定期的な健康診断による早期発見の重要な役割を強調しています。同団体は、バルーン弁形成術のような症状や利用可能な治療法について一般の人々に知らせることを目的としています。

バルーン弁形成術装置市場レポートハイライト

  • 用途別では、大動脈弁狭窄症分野が2023年に64%超の最大シェアを占めました。世界の心臓弁膜症罹患率の上昇と技術の進歩が、このセグメントの成長を牽引しています。
  • 最終用途別では、病院セグメントが2023年に57.4％で最大の収益シェアを占めました。世界的に心臓弁膜症の罹患率が上昇しているため、患者のケアを効果的に管理するための高度なソリューションが病院内で必要とされています。
  • 北米は2023年に41.4%のシェアで市場を独占したが、これは心臓弁膜症を含む心血管疾患の症例が増加しているためです。製品の発売、規制当局の承認、高度なヘルスケアインフラが、バルーン弁形成術装置の需要を促進しています。
  • バルーン弁形成術装置市場には、B. Braun Interventional Systems, Inc.、BD Interventional、Edwards Lifesciences、Boston Scientific Corporation、Getinge、Toray International America, Inc.、Stryker、BrosMed Medical、Medtronic、Terumo Corporation、Philipsなどの企業が参入しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 世界のバルーン弁形成術装置市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場牽引要因分析
    • 市場抑制要因分析
  • バルーン弁形成術装置市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 バルーン弁形成術装置市場：用途の推定・動向分析

  • バルーン弁形成術装置市場：用途ダッシュボード
  • バルーン弁形成術装置市場：用途変動分析
  • 用途別、2018～2030年
  • 大動脈弁狭窄症
  • 肺動脈弁狭窄症

第5章 バルーン弁形成術装置市場：最終用途の推定・動向分析

  • バルーン弁形成術装置市場：最終用途ダッシュボード
  • バルーン弁形成術装置市場：最終用途変動分析
  • 最終用途別、2018～2030年
  • 病院
  • 外来手術センター（ASC）
  • 心臓カテーテル検査室

第6章 バルーン弁形成術装置市場：地域推定・動向分析

  • 世界のバルーン弁形成術装置市場：地域別ダッシュボード
  • 地域別、2018年から2030年
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第7章 競合情勢

  • 主要メーカーによる最近の動向と影響分析
  • 企業/競合の分類
  • ベンダー情勢
    • 主要販売代理店およびチャネルパートナーのリスト
    • Key customers
    • Key company market share analysis, 2023
    • B. Braun Interventional Systems, Inc.
    • BD Interventional
    • Edwards Lifesciences
    • Boston Scientific Corporation
    • Getinge
    • Toray International America, Inc.
    • Stryker
    • BrosMed Medical
    • Medtronic
    • Terumo Corporation
    • Philips
図表

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviation
  • Table 3. Global balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 4. Global balloon valvuloplasty devices market, by end-use, 2018 - 2030
  • Table 5. Global balloon valvuloplasty devices market, by region, 2018 - 2030 (USD Million)
  • Table 5. North America balloon valvuloplasty devices market, by country, 2018 - 2030 (USD Million)
  • Table 6. North America balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 7. North America balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 8. U.S. balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 9. U.S. balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 10. Canada balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 11. Canada balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 12. Mexico balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 13. Mexico balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 14. Europe balloon valvuloplasty devices market, by country, 2018 - 2030 (USD Million)
  • Table 15. Europe balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 16. Europe balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 17. U.K. balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 18. U.K. balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 19. Germany balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 20. Germany balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 21. France balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 22. France balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 23. Italy balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 24. Italy balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 25. Spain balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 26. Spain balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 27. Denmark balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 28. Denmark balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 29. Sweden balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 30. Sweden balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 31. Norway balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 32. Norway balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 33. Asia Pacific balloon valvuloplasty devices market, by country, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 35. Asia Pacific balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 36. Japan balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 37. Japan balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 38. China balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 39. China balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 40. India balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 41. India balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 42. Australia balloon valvuloplasty devices market, by country, 2018 - 2030 (USD Million)
  • Table 43. Australia balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 44. Australia balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 45. Thailand balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 46. Thailand balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 47. South Korea balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 48. South Korea balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 49. Latin America balloon valvuloplasty devices market, by country, 2018 - 2030 (USD Million)
  • Table 50. Latin America balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 51. Latin America balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 52. Brazil balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 53. Brazil balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 54. Argentina balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 55. Argentina balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 56. MEA balloon valvuloplasty devices market, by country, 2018 - 2030 (USD Million)
  • Table 57. MEA balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 58. MEA balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 59. South Africa balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 60. South Africa balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 62. Saudi Arabia balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 63. UAE balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 64. UAE balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 65. Kuwait balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 66. Kuwait balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 67. Participant's overview
  • Table 68. Financial performance
  • Table 69. Key companies undergoing expansions
  • Table 70. Key companies undergoing acquisitions
  • Table 71. Key companies undergoing collaborations
  • Table 72. Key companies launching new products
  • Table 73. Key companies undergoing partnerships
  • Table 74. Key companies undertaking other strategies

List of Figures

  • Fig. 1 Balloon valvuloplasty devices market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Balloon valvuloplasty devices market revenues, 2023, (USD Millions)
  • Fig. 9 Market driver relevance analysis (Current & future impact)
  • Fig. 10 Market restraint relevance analysis (Current & future impact)
  • Fig. 11 Porter's five forces analysis
  • Fig. 12 PESTLE analysis
  • Fig. 13 Balloon valvuloplasty devices market application outlook:
  • Fig. 14 Balloon valvuloplasty devices market: application movement analysis
  • Fig. 15 Global aortic valve stenosis market, 2018 - 2030 (USD Million)
  • Fig. 16 Global pulmonary valve stenosis market, 2018 - 2030 (USD Million)
  • Fig. 17 Balloon valvuloplasty devices market end-use outlook:
  • Fig. 18 Balloon valvuloplasty devices market: end-use movement analysis
  • Fig. 19 Global hospitals market, 2018 - 2030 (USD Million)
  • Fig. 20 Global ambulatory surgical centers (ASCs) market, 2018 - 2030 (USD Million)
  • Fig. 21 Global cardiac catheterization labs market, 2018 - 2030 (USD Million)
  • Fig. 22 Regional market place: Key takeaways
  • Fig. 23 North America balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 24 U.S. balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 25 Canada balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 26 Mexico balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 27 Europe balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 28 Germany balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 29 U.K. balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 30 France balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 31 Italy balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 32 Spain balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 33 Asia Pacific balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 34 Japan balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 35 China balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 36 India balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 37 Australia balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 38 Latin America balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 39 Brazil balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 40 MEA balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 41 South Africa balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 42 Saudi Arabia balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 43 Market Participant Categorization
  • Fig. 44 Strategy mapping
目次
Product Code: GVR-4-68040-438-3

Balloon Valvuloplasty Devices Market Growth & Trends:

The global balloon valvuloplasty devices market size is expected to reach USD 3.02 billion by 2030, registering a CAGR of 4.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of cardiovascular diseases, including valvular heart diseases, new product launches, regulatory approvals, and advanced healthcare infrastructure, drives the demand for balloon valvuloplasty devices in North America. Rheumatic heart disease (RHD) is a serious cardiovascular condition that arises from damage to the heart valves due to rheumatic fever.

According to a report published by the American Heart Association in April 2024, valvular heart disease (VHD) is among the most prevalent health conditions in the U.S., affecting about 2.5% of the adult population. Aortic and mitral valve diseases are the most diagnosed types of VHD, further emphasizing the critical need for effective treatment options like balloon valvuloplasty devices to address this growing health concern.

Increasing awareness and screening programs fuel the market's growth. For instance, in September 2024, the Global Heart Hub initiated campaigns highlighting the rising prevalence of heart valve disease, which is expected to double by 2040 and triple by 2060. These efforts stress the critical role of early detection through regular medical check-ups. The organization aims to inform the public about the symptoms and available treatments, such as balloon valvuloplasty.

Balloon Valvuloplasty Devices Market Report Highlights:

  • Based on application, the aortic valve stenosis segment held the largest share, over 64%, in 2023. The global rise in the incidence of valvular heart diseases and technological advancements drive the segment's growth
  • Based on end use, the hospital segment held the largest revenue share at 57.4% in 2023. The rising incidence of valvular heart diseases globally necessitates advanced solutions within hospitals to manage patient care effectively
  • North America dominated the market with a share of 41.4% in 2023, owing to the rising cases of cardiovascular diseases, including valvular heart diseases. Product launches, regulatory approvals, and advanced healthcare infrastructure drive the demand for balloon valvuloplasty devices
  • Market players operating in the balloon valvuloplasty devices market include B. Braun Interventional Systems, Inc., BD Interventional, Edwards Lifesciences, Boston Scientific Corporation, Getinge, Toray International America, Inc., Stryker, BrosMed Medical, Medtronic, Terumo Corporation, Philips

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. End-use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecast timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity price analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application Segment
    • 2.2.2. End-use Segment
    • 2.2.3. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Balloon Valvuloplasty Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of valvular heart diseases
      • 3.2.1.2. Technological advancements in balloon valvuloplasty devices
      • 3.2.1.3. Increasing awareness and screening programs
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost associated with the devices and procedures
      • 3.2.2.2. Regulatory compliance
  • 3.3. Balloon Valvuloplasty Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Balloon Valvuloplasty Devices Market: Application Estimates & Trend Analysis

  • 4.1. Balloon Valvuloplasty Devices Market: Application Dashboard
  • 4.2. Balloon Valvuloplasty Devices Market: Application Movement Analysis
  • 4.3. Balloon Valvuloplasty Devices Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 4.4. Aortic Valve Stenosis
    • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5. Pulmonary Valve Stenosis
    • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Balloon Valvuloplasty Devices Market: End-use Estimates & Trend Analysis

  • 5.1. Balloon Valvuloplasty Devices Market: End-use Dashboard
  • 5.2. Balloon Valvuloplasty Devices Market: End-use Movement Analysis
  • 5.3. Balloon Valvuloplasty Devices Market Size & Forecasts and Trend Analysis, by End-use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5. Ambulatory Surgical Centers (ASCs)
    • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.6. Cardiac Catheterization Labs
    • 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Balloon Valvuloplasty Devices Market: Regional Estimates & Trend Analysis by Country, Application, & End-use

  • 6.1. Global Balloon Valvuloplasty Devices Market: Regional Dashboard
  • 6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
  • 6.3. North America
    • 6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.4. Mexico
      • 6.3.4.1. Key country dynamics
      • 6.3.4.2. Regulatory framework/ reimbursement structure
      • 6.3.4.3. Competitive scenario
      • 6.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.2. UK
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.9. Denmark
      • 6.4.9.1. Key country dynamics
      • 6.4.9.2. Regulatory framework/ reimbursement structure
      • 6.4.9.3. Competitive scenario
      • 6.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.3. Japan
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.5. Australia
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.7. South Korea
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Regulatory framework/ reimbursement structure
      • 6.5.7.3. Competitive scenario
      • 6.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.3. South Africa
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. B. Braun Interventional Systems, Inc.
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. BD Interventional
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Edwards Lifesciences
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Boston Scientific Corporation
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Getinge
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Toray International America, Inc.
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Stryker
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. BrosMed Medical
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Medtronic
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. Terumo Corporation
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Product benchmarking
      • 7.3.13.4. Strategic initiatives
    • 7.3.14. Philips
      • 7.3.14.1. Company overview
      • 7.3.14.2. Financial performance
      • 7.3.14.3. Product benchmarking
      • 7.3.14.4. Strategic initiatives